Small Business Scholarship funding is provided through the support of the Wisconsin Economic Development Corporation and is a benefit of BioForward membership. A 30% dollar match will need to be shown and evidence of such provided to BioForward for this grant.
The 2018 BIO International Convention, June 4-7, 2018 in Boston, is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. The key benefits of attending the 2018 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders with over 500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 74 countries.
Scholarship Application Deadline: April 27, 2018
Scholarship Awards Announced: May 4, 2018
Proof of Registration and Attendance to BioForward: June 15, 2018
BioForward was able to support 30 scholarships for Wisconsin companies to attend the conference and we're thrilled to be able to support them financially to make inroads with international partners at BIO 2018.
Aldevron serves the biotechnology industry with custom production of nucleic acids, proteins and antibodies.
Alithias provides population health data analytics and patient advocacy services to more than 60 employers covering >60,000 lives.
BloodCenter of Wisconsin (part of Versiti) combines an unparalleled experience in transfusion medicine, transplantation, stem cells and cellular therapies, oncology and genomics, diagnostic lab services, and medical and scientific expertise.
Biomax Informatics specializes in research software for bioinformatics.
BrainXell provides iPSC-derived human neurons to the pharmaceutical industry and other research organizations for CNS drug discovery and development.
Co-D Therapeutics, Inc. is a preclinical stage pharmaceutical company developing novel and transforming combination therapies with high safety profiles to treat cancer.
DNASTAR provides useful, affordable, accessible genomics software to a broad a range of life scientists.
ENDECE has discovered a drug for inducing remyelination in devastating demyelinating diseases such as multiple sclerosis.
Imbed Biosciences is a developing stage tissue engineering company commercializing patented advanced bioresorbable materials for soft-tissue repair and regeneration.
Intense Engineering designs, develops and builds turnkey automated systems, custom equipment and products for life science companies.
Intuitive Biosciences provides diagnostic solutions to improve workflow and provide the most accurate results, providing the expertise needed to rapidly convert or build new multiplex immunoassays.
InvivoSciences Inc. is a pioneering developer of functional human tissues and award-winning high-throughput phenotype analyzer for drug & biomarker discovery.
Jace Biomedical, Inc. is a pre-clinical stage pharmaceutical company developing small molecules for the treatment of Alzheimer’s disease (AD).
NeoClone excels at the discovery and development of single chain and single domain antibodies using phage techniques as well as the ability to molecularly modify antibodies.
NeuroSolis, Inc. is an early-stage company developing NSX-0527 for neurological and psychiatric indications.
Regenerative Medical Solutions provides pluripotent stem cell-derived pancreatic beta cells throughout the world for use in drug discovery, toxicity, efficacy testing and as a potential therapeutic platform for diabetes.
Scarab Genomics commercializes bioengineered E. coli to produce DNA and protein.
Stem Pharm is developing advanced biomaterials for stem cell discovery and therapy applications.
True Process is an ISO 13485 certified healthcare IT firm focused on medical software engineering for connected medical devices.
Yahara Software creates custom enterprise software solutions to optimize workflows, collect and analyze data, and visualize results for their specialized IT needs in the life sciences, healthcare, and biotechnology arenas.
With Grant Support From:
The 2018 HIMSS Annual Conference & Exhibition, March 5–9, 2018 in Las Vegas, brought together 45,000+ professionals from around the world for five days of education, innovation and collaboration to help uncover the promise of health information and technology. No other conference brings you the world-class education, cutting-edge products and solutions, and unique networking opportunities you need to solve your biggest health information and technology challenges – all at one time, all in one place. Choose from 300+ education sessions, 1,300+ vendors, hundreds of special programs, and endless networking events. HIMSS18: Where the World Connects for Health.
BioForward was able to support 8 Wisconsin companies in attending the conference and we're thrilled to be able to support them financially to make inroads with international partners at HIMSS 2018.
Yahara Software clients come from the life sciences, healthcare, and biotechnology arenas and need a trusted partner to understand their unique challenges. We create custom enterprise software solutions to optimize workflows, collect and analyze data, and visualize results for their specialized IT needs. We partner with our clients, working hard to ensure they have the best possible software technology supporting their goals. Our clients strive to improve people’s lives on a global scale and we are proud to be a part of their missions.
Ancilla Partners is a healthcare technology firm based in Milwaukee. We have built many web applications in the healthcare quality, data, and reporting sector for organizations in Wisconsin and across the country. Recently we have changed our focus to product (software as a service) development.
Healthio is building an intelligent platform for preventive and predictive healthcare. Healthcare has become sick-care. Globally we are dealing with an escalating cost of care along with a deterioration in quality due to a break-fix model. healthio focuses on the 5000 hours away from the doctor and tries to understand changes in individual physiology along with social and environmental factors to predict health outcomes.
Alithias is a healthcare data analytics and patient advocacy company providing population health analytics and advocacy services to over 40 WI companies and more than 40,000 lives. Our platform provides unique data visualization capabilities that make the data actionable to users and case managers. Our program is proven to save employers 3% - 12% of their claims costs and we have a 98% client retention rate since launch.
Spaulding Medical's ECG Mangement System is disrupting traditional cardiac management in hospital and ambulatory markets. Our software offers a centralized, interoperable hub for cardiac data within EMRs, and our wireless and portable hardware solutions simplify the acquisition and clinical analysis of cardiac data anywhere at anytime.
Wellbe enables high-performing health systems throughout the U.S. to transform care models by improving patients’ experiences, satisfaction, and health outcomes while reducing costs. Wellbe’s cloud-based platform facilitates connected care between patients and healthcare providers across an episode such as a joint replacement surgery, empowering patients to participate as active partners in their treatment, and giving providers the ability to monitor large numbers of patients more effectively.
Physician Compass extracts and compiles patient/visit level data for physician quality metrics to be used with government compliance programs as well as health system quality improvement programs. HIMSS is a great forum to review potential new business opportunities with the data that we manage.
Lohman Technologies provides a superior digital health solution for cost effective detection and long-term management of cardiac arrhythmias - anytime and anywhere. Through ongoing development and introduction of IoT (internet of things) monitoring solutions and artificial intelligence through advanced algorithms, the company intends to secure and maintain a leadership position in the remote cardiac monitoring market by providing healthcare providers, digital health platforms and patients with very accurate, easy to use, and cost-effective monitoring solutions that produce high quality, clinical data and accurate detection of arrhythmias.
With Grant Support From: